FindTrial
Sign In

COMPARISON OF EFFICACY OF PRITCHARD AND ZUSPAN REGIMEN OF MAGNESIUM SULPHATE IN SEVERE PREECLAMPSIA AND ECLAMPSIA

Comparison of efficacy of Pritchard and Zuspan regimen of Magnesium Sulphate in severe preeclampsia and eclampsia - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054559
Enrollment
250
Registered
2023-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O141- Severe pre-eclampsia

Interventions

Control Intervention1: Magnesium sulphate regimen- pritchard and zuspan: In patients of severe preeclampsia and eclampsia, EFFICACY OF ZUSPAN REGIMEN WILL BE COMPARED WITH EFFICACY OF PRITCHARD REGIME

Sponsors

Vardhman Mahavir Medical College and Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PREECLAMPSIA PATIENTS ECLAMPSIA PATIENTS

Exclusion criteria

Exclusion criteria: 1) Chronic kidney disease 2) Cardiac patients 3) Contraindications to MgSO4 due to drug hypersensitivity, myasthenia gravis, anuria, oliguria

Design outcomes

Primary

MeasureTime frame
recurrent convulsions in eclamptic patients new onset convulsions in severe preeclampsia patientsTimepoint: during study period—

Secondary

MeasureTime frame
pulmonary edema fetal outcomes Serum magnesium levelsTimepoint: during study period—

Countries

India

Contacts

Public ContactDr Kanchan Basnet

VMMC AND SAFDARJUNG HOSPITAL NEW DELHI 110029

saritasingh_og@yahoo.co.in8826625892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026